
Global Biotechnology Company | CSL
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Together they help ensure people everywhere get the treatments they need.
Global Biotechnology Company | CSL
CSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases.
Our Businesses and Products | CSL
For over a century, we’ve been an unstoppable force, from developing medicines that save and improve lives to vaccines that protect them. Today, with the combined expertise of CSL Behring (with …
We Are CSL | CSL
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients' needs by using the latest technologies, we discover, develop and deliver innovative …
Worldwide Locations | CSL
Biotech leader CSL has manufacturing centers, sales offices, and locations to serve patients and public health around the globe.
Global plasma collector | CSL
CSL Plasma operates one of the world’s largest and most sophisticated plasma collection networks, with nearly 330 plasma donation centers globally, including the U.S. and Europe and employs nearly …
Global Newsroom | CSL
Nov 18, 2025 · The CSL Seqirus site in Tullamarine, Melbourne, will be capable of supplying Australia with cell-based flu vaccine and meeting future demand from Asia, Europe, the Middle East and South …
Careers | CSL
CSL offers Promising FUTURES, find yours here CSL was established in Australia in 1916. Over the ensuing years, CSL provided Australians with rapid access to 20th century medical advances …
Financial Results and Information | Global Biotechnology Company | CSL
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Together they help ensure people everywhere get the treatments they need.
Research and Development | CSL
Investment in R&D is an important driver for CSL’s future growth. New and exciting opportunities allow us to address previously unmet patient needs and these continue to drive us each day. In addition, …